1,031
Views
9
CrossRef citations to date
0
Altmetric
Original Article

A new ester of fatty acid from a methanol extract of the whole plant of Amaranthus spinosus and its α-glucosidase inhibitory activity

, &
Pages 600-604 | Received 03 Mar 2014, Accepted 12 Jun 2014, Published online: 23 Oct 2014
 

Abstract

Context: Amaranthus spinosus Linn. (Amaranthaceae), commonly known as “spiny pigweed”, is used both in the Indian traditional system and in folk medicine to treat diabetes.

Objective: The present study evaluates the scientific basis of antidiabetic activity of chloroform fraction of methanol extract of A. spinosus and of an isolated constituent of A. spinosus.

Materials and methods: HPLC analysis was performed to determine the purity and the amount of the constituent present in the plant extract. The yeast α-glucosidase inhibition technique was used to determine the antidiabetic activity of A. spinosus. Acarbose was used as a standard. An appropriate therapeutic approach for preventing diabetes mellitus and obesity is to retard the absorption of glucose by inhibition of α-glucosidase.

Results: One novel fatty acid with strong α-glucosidase inhibitory activity – (14E, 18E, 22E, 26E) – methyl nonacosa-14, 18, 22, 26 tetraenoate [1] (IC50 value 6.52 µM/mL) and β-sitosterol [2] were purified. Compound 1 was found to be more potent than the methanol extract. HPLC quantative analysis revealed that 0.15% of compound 1 and 0.06% of compound 2 were present in the plant extract.

Conclusion: This novel fatty acid can potentially be developed as a novel natural nutraceutical for the management of diabetes.

Acknowledgements

The authors would like to thank Jadavpur University, Kolkata, India, for providing research facilities and CSIR-Indian Institute of Chemical Biology, Kolkata, India, for instrumental analysis facilities.

Declaration of interest

The authors have no conflicts of interests.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.